Publications by authors named "Tatjana Schmidt"
Article Synopsis
- Phase three trials of the monoclonal antibodies lecanemab and donanemab have shown promising results in treating early Alzheimer’s disease, with some countries already using these drugs while the UK is considering them for regulatory approval.
- A study estimated that around 906 individuals per year in two National Health Service trusts qualify for these treatments based on clinical trial criteria, suggesting a national demand of about 30,200 patients.
- The findings indicate that implementing these monoclonal antibody treatments could strain healthcare resources, highlighting the need for careful planning to meet the potential demand for such therapies in the UK.
The recognition of human speakers by their voices is a remarkable cognitive ability. Previous research has established a voice area in the right temporal cortex involved in the integration of speaker-specific acoustic features. This integration appears to occur rapidly, especially in case of familiar voices.
View Article and Find Full Text PDFDiagnostic imaging of jejuno-ileal neuroendocrine tumors (NETs) has been described as challenging. Follow-up requires the detection of metastatic spread as well as screening for local recurrence. Multimodal imaging concepts must often be applied.
View Article and Find Full Text PDF